Focal therapy for localized prostate cancer: A phase I/II trial

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1246-1254

  Ahmed, H U ^a,b   Freeman, A ^b   Kirkham, A ^b   Sahu, M ^e   Scott, R ^a   Allen, C ^b   Van Der Meulen, J ^c,d   Emberton, M ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e NONE

Author keywords

biopsy; high intensity focused ultrasound ablation; magnetic resonance imaging; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER THERAPY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; PENIS ERECTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL FUNCTION; SEXUAL SATISFACTION; TREATMENT RESPONSE; URINARY TRACT FUNCTION;

AGED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 79952707972     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.11.079     Document Type: Article

References (30)

1. Wilt TJ, MacDonald R, Rutks I et al: Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435.
2. Cooperberg MR, Broering JM and Carroll PR: Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28: 1117.
3. Klotz L, Zhang L, Lam A et al: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28: 126.
4. Tseng KS, Landis P, Epstein JI et al: Risk strati- fication of men choosing surveillance for low risk prostate cancer. J Urol 2010; 183: 1779.
5. Ahmed HU, Pendse D, Illing R et al: Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007; 4: 632.
6. Eggener SE, Scardino PT, Carroll PR et al: Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178: 2260.
7. Bostwick DG, Waters DJ, Farley ER et al: Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology 2007; 70: 42.
8. Stamey TA, Caldwell M, McNeal JE et al: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? J Urol 2004; 172: 1297.
9. Sherwin JC, Mirmilstein G, Pedersen J et al: Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors. J Urol 2010; 183: 1808.
10. Uhlman MA, Sun L, Stackhouse DA et al: Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate. J Urol 2010; 183: 997.
11. von Elm E, Altman DG, Egger M et al: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453.
12. Medical Research Council Health Services and Public Health Research Board: A framework for development and evaluation of RCTs for complex interventions to improve health. London: Medical Research Council 2000.
13. Barzell WE and Melamed MR: Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate-a 4-year experience. Urology 2007; 70: 27.
14. Machin D, Campbell M, Fayers P et al: Sample Size Tables for Clinical Studies, 2nd ed. Oxford: Blackwell Science 1997; pp. 21-22.
15. Ahmed HU, Zacharakis E, Dudderidge T et al: High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br J Cancer 2009; 101: 19.
16. D'Amico AV, Whittington R, Malkowicz SB et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969.
17. Litwin MS, Hays RD, Fink A et al: The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002.
18. Esper P, Mo F, Chodak G et al: Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997; 50: 920.
19. Rosen RC, Cappelleri JC, Smith MD et al: Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319.
20. Rosen RC, Riley A, Wagner G et al: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822.
21. Webster K, Cella D and Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003; 1: 79.
22. Esserman L, Shieh Y and Thompson I: Rethinking screening for breast cancer and prostate cancer. JAMA 2009; 302: 1685.
23. Epstein JI, Walsh PC, Carmichael M et al: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368.
24. Onik G, Vaughan D, Lotenfoe R et al: The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008; 26: 500.
25. Bahn DK, Silverman P, Lee F Sr et al: Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 2006; 20: 688.
26. Lambert EH, Bolte K, Masson P et al: Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 2007; 69: 1117.
27. Muto S, Yoshii T, Saito K et al: Focal therapy with high-intensity- focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008; 38: 192.
28. Hu JC, Gu X, Lipsitz SR et al: Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009; 302: 1557.
29. Zietman A: Evidence-based medicine, conscience- based medicine, and the management of low-risk prostate cancer. J Clin Oncol 2009; 27: 4935.
30. Ahmed HU: The index lesion and the origin of prostate cancer. N Engl J Med 2009; 361: 1704.